Protective immunity against murine candidiasis elicited by Candida albicans ribosomal fractions.

Infection and Immunity
R LevyE Eylan

Abstract

Candida albicans ribosomes were prepared from mechanically disrupted cells through differential centrifugation and purification in a sucrose-ammonium sulfate solution. The ribosomes were analyzed chemically and physically and exhibited characteristics of eucaryotic ribosomes (78S). ICR female mice were immunized with two subcutaneous inoculations, 2 weeks apart, of 100 microgram of ribosomes (expressed as ribosomal protein). Immunized mice were challenged either intraperitoneally or intravenously with a lethal dose of live C. albicans cells. The 31-day survival rate of immunized mice challenged intraperitoneally was 64% (mean value) versus 27% in controls; in intravenously challenged mice the survival rate of the immunized animals was about 60%, with no survivors among the controls. In intravenously challenged mice, incomplete Freund adjuvant enhanced the protection elicited by the ribosomes. Protection by ribosomal immunization was obtained against challenge doses causing chronic and acute infection.

References

May 1, 1979·Infection and Immunity·L H FieldL J Berry
Feb 1, 1977·Infection and Immunity·M LynnM Solotorovsky
Jan 1, 1975·Methods in Cell Biology·G M Rubin
Nov 1, 1971·The New England Journal of Medicine·C R Curry, P G Quie
Apr 1, 1972·Archives of Surgery·B G MacMillanI A Holder
Aug 1, 1969·The Journal of Infectious Diseases·P D HartJ S Remington
Jun 1, 1967·Sabouraudia·P SolesD B Louria
Jan 1, 1980·Infection and Immunity·L L LeonA O Lima
Mar 1, 1961·Proceedings of the Society for Experimental Biology and Medicine·S MOURAD, L FRIEDMAN
Sep 1, 1963·Journal of Bacteriology·H F HASENCLEVER, W O MITCHELL
Oct 1, 1964·Proceedings of the National Academy of Sciences of the United States of America·M M TAYLOR, R STORCK
May 1, 1965·Journal of Bacteriology·A S YOUMANS, G P YOUMANS
Jun 1, 1970·Infection and Immunity·M R VennemanL J Berry

❮ Previous
Next ❯

Citations

Jan 1, 1994·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·C F XidiehE Burger
Dec 11, 1999·The Journal of Antimicrobial Chemotherapy·Y Shadkchan, E Segal
Apr 2, 2009·Dermatologic Therapy·Kelly ConnerStephen K Tyring
Apr 19, 2005·Medical Mycology·A Brian Mochon, Jim E Cutler
Dec 23, 2006·Expert Review of Vaccines·Antonio Cassone, Antonella Torosantucci
Jan 1, 1987·Critical Reviews in Microbiology·E Segal
Feb 9, 2018·Journal of Fungi·Esther Segal, Michael Frenkel
Feb 1, 2020·International Journal of Biological Macromolecules·Kannan Badri NarayananSung Soo Han
Oct 1, 1991·Infection and Immunity·V I LevensonZ K Stassilevich
Jul 1, 1983·Infection and Immunity·G E Winterrowd, J E Cutler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.